Lisa A. Ware

Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

Michele Spring, James F. Cummings, Christian F. Ockenhouse et al. · PLoS ONE · 2009 · 207 citations · Full text

Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy

Jason W. Bennett, Anjali Yadava, Donna Tosh et al. · PLoS neglected tropical diseases · 2016 · 129 citations · Full text

First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers

Michele Spring, Jittawadee Murphy, Robin Nielsen et al. · Vaccine · 2013 · 128 citations

Entomology, Malaria, Parasite Control +9

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

J A Tine, David E. Lanar, Darlene Smith et al. · Infection and Immunity · 1996 · 125 citations · Full text

Vaccination, Vaccine Development, Parasite Life Cycle +11

Purification, Characterization, and Immunogenicity of the Refolded Ectodomain of the <i>Plasmodium falciparum</i> Apical Membrane Antigen 1 Expressed in <i>Escherichia coli</i>

Sheetij Dutta, P.V. Lalitha, Lisa A. Ware et al. · Infection and Immunity · 2002 · 107 citations · Full text